×

LLS venture philanthropy invests in five immunotherapy companies

Published Apr 27 2021 at 4:01 AM GMT
Key
Points
  • The Leukemia & Lymphoma Society Therapy Acceleration Program, a venture philanthropy initiative, has announced five investments aimed at accelerating the development of new and improved immunotherapies for the treatment of blood cancers.




Trending

Stats

  • Published Apr 27, 2021 4:01 AM GMT